BRIEF-Valeant seeing 'anxiety' among US staff, will expand retention program - spokeswoman

Wed Nov 18, 2015 9:03am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Nov 18 (Reuters) - Valeant Pharmaceuticals International Inc

* Likely to make tuck-in acquisitions, but debt repayment the focus - spokeswoman

* On track to meeting Salix inventory goal

* Spokeswoman speaking at London health care conference Further company coverage: (Reporting By Rod Nickel)